Combined, infection, autoimmunity and cancer account for 4 out of every 10 deaths worldwide, and represent major global health challenges. In a paper in the journal Cell Reports, Institute for Systems Biology (ISB) researchers ...
Mar 4, 2024
0
121
There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times ...
Mar 4, 2024
0
0
A University of Cincinnati Cancer Center study has found that real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
Feb 29, 2024
0
0
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
37
People in the UK have been treated with chemotherapy and radiotherapy less often than patients in comparable countries, and faced long waits for treatments, according to two new studies published in The Lancet Oncology.
Feb 26, 2024
0
0
A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results, ...
Feb 23, 2024
0
29
For adults with acute myeloid leukemia (AML), those with central nervous system (CNS) involvement have worse overall survival, according to a review published in the February issue of Leukemia Research.
Feb 21, 2024
0
0
Patients with therapy-related myelodysplastic syndrome (t-MDS) and de novo MDS have comparable outcomes after haploidentical hematopoietic stem cell transplantation (haplo-HSCT), according to a study published online Feb. ...
Feb 21, 2024
0
0
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding and managing this disease.
Feb 16, 2024
0
0
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil—together referred to as NALIRIFOX—has been approved by the U.S. Food and Drug Administration ...
Feb 16, 2024
0
4
